Skip to content
Gene therapy: AAV

Gene therapy: AAV

AAV - Production platforms for gene therapy development

Licensable AAV production platforms

Efficient, scalable and cost-effective platforms for vector engineering

OXGENE helps solve the challenge of scalable manufacture for gene therapy.

Our GMP-compliant solutions accelerate the development of novel therapeutics, ensuring consistent quality of rAAV vectors and minimising risk during the product development lifecycle.

Resource updated on 18/2/2021

Download the resource to read on...

We use cookies to give you the best experience of using this website. By continuing to use this site, you accept our use of cookies. Please read our Cookie Policy for more information.

Our single technology platform that fully connects our smart labs with our customer service proposition.


Connex revolutionises DNA design, optimization and assembly by ensuring the highest levels of quality control, efficiency and project management available for any client.

OXGENE has fully integrated all its smart labs and robotic production processes within a single technology platform that allows real-time project updates for our customers.